Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
American Financial Group
AFG
$12B
| $248K | ﹤0.01% |
1,700
-24,900
| -94% | -$3.4M |
|
|
KALV
3552
DELISTED
KalVista Pharmaceuticals
KALV
| $248K | ﹤0.01% |
16,800
-5,627
| -25% | -$80.8K |
|
|
FNA
3553
DELISTED
Paragon 28, Inc.
FNA
| $248K | ﹤0.01% |
+14,800
| New | +$238K |
|
|
EBET
3554
DELISTED
EBET, INC. Common Stock
EBET
| $248K | ﹤0.01% |
+1,227
| New | +$382K |
|
3555
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.63B
| $247K | ﹤0.01% |
+2,800
| New | +$244K |
|
3556
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.07B
| $247K | ﹤0.01% |
10,300
-639
| -6% | -$15.7K |
|
3557
Edesa Biotech
EDSA
$52.3M
| $246K | ﹤0.01% |
11,829
+7,100
| +150% | +$197K |
|
|
NOAH
3558
Noah Holdings
NOAH
$588M
| $245K | ﹤0.01% |
10,400
-18,900
| -65% | -$531K |
|
|
ALP
3559
Alpha Compute
ALP
$3.99M
| $245K | ﹤0.01% |
1,865
+500
| +37% | +$85.9K |
|
|
CCM
3560
Concord Medical Services
CCM
$20.8M
| $244K | ﹤0.01% |
14,260
-1,250
| -8% | -$24.3K |
|
3561
Garrett Motion
GTX
$5.47B
| $244K | ﹤0.01% |
33,900
-2,100
| -6% | -$15.1K |
|
3562
Farmmi Inc
FAMI
$4.96M
| $242K | ﹤0.01% |
668
-2,625
| -80% | -$1.2M |
|
3563
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$311M
| $242K | ﹤0.01% |
+9,500
| New | +$235K |
|
3564
Sonoma Pharmaceuticals
SNOA
$6.56M
| $242K | ﹤0.01% |
3,018
-95
| -3% | -$6.87K |
|
3565
DXP Enterprises
DXPE
$3.04B
| $241K | ﹤0.01% |
8,900
-30,600
| -77% | -$868K |
|
3566
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$494M
| $240K | ﹤0.01% |
+6,000
| New | +$271K |
|
3567
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.44B
| $240K | ﹤0.01% |
3,400
-3,400
| -50% | -$238K |
|
|
DVLT
3568
Datavault AI
DVLT
$277M
| $240K | ﹤0.01% |
13
-4
| -24% | -$73.3K |
|
|
CYTH
3569
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $240K | ﹤0.01% |
75,787
+9,487
| +14% | +$33.2K |
|
3570
Daxor
DXR
$59.5M
| $239K | ﹤0.01% |
22,421
+600
| +3% | +$6.58K |
|
3571
Certara
CERT
$1.24B
| $238K | ﹤0.01% |
11,100
-114,000
| -91% | -$2.74M |
|
|
FURY
3572
Fury Gold Mines
FURY
$116M
| $238K | ﹤0.01% |
350,923
+66,214
| +23% | +$45.4K |
|
3573
Magyar Bancorp
MGYR
$126M
| $238K | ﹤0.01% |
20,200
-400
| -2% | -$4.85K |
|
3574
Neonode
NEON
$14.8M
| $238K | ﹤0.01% |
39,211
-24,489
| -38% | -$136K |
|
3575
Teekay Tankers
TNK
$2.81B
| $238K | ﹤0.01% |
+17,200
| New | +$209K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.